Literature DB >> 6432838

Demonstration of uronic acid capsular material in the cerebrospinal fluid of a patient with meningitis caused by mucoid Pseudomonas aeruginosa.

D Stevens, M Lieberman, T McNitt, J Price.   

Abstract

A 39-year-old female with insulin-dependent diabetes mellitus developed Rhizopus infection of the maxillary sinus. Subsequent to successful treatment with amphotericin B and surgical debridement, she developed purulent meningitis due to a mucoid strain of Pseudomonas aeruginosa. Analysis of cerebrospinal fluid documented the presence of a uronic acid polymer at a concentration of 40 micrograms/ml. In spite of parenteral and intrathecal antibiotic therapy, the patient died. This case illustrates that mucoid strains of P. aeruginosa may result in fatal infection and that alginate capsule is produced in vivo in humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432838      PMCID: PMC271222          DOI: 10.1128/jcm.19.6.942-943.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Biosynthesis of alginate. 1. Composition and structure of alginate produced by Azotobacter vinelandii (Lipman).

Authors:  B Larsen; A Haug
Journal:  Carbohydr Res       Date:  1971-04       Impact factor: 2.104

2.  A new modification of the carbazole analysis: application to heteropolysaccharides.

Authors:  C A Knutson; A Jeanes
Journal:  Anal Biochem       Date:  1968-09       Impact factor: 3.365

3.  Mucoid Pseudomonas aeruginosa in patients with chronic illnesses.

Authors:  R G Doggett; G M Harrison; R E Carter
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

4.  Slime production by Pseudomonas aeruginosa. IV. Chemical analysis of two varieties of slime produced by Pseudomonas aeruginosa.

Authors:  T Murakawa
Journal:  Jpn J Microbiol       Date:  1973-11

5.  Composition of the protective antigen from the slime layer of Pseudomonas aeruginosa.

Authors:  S C Cha; J A Bass; M R Shetlar
Journal:  Tex Rep Biol Med       Date:  1971

6.  Influence of mucoidy on antibody coating of Pseudomonas aeruginosa.

Authors:  T J Marrie; G K Harding; A R Ronald; J Dikkema; J Lam; S Hoban; J W Costerton
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

7.  Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

8.  Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.

Authors:  R G Doggett; G M Harrison
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

9.  Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.

Authors:  L R Evans; A Linker
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

10.  Purification and Chemical Composition of the Protective Slime Antigen of Pseudomonas aeruginosa.

Authors:  P F Bartell; T E Orr; B Chudio
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

  10 in total
  2 in total

1.  Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response.

Authors:  S S Pedersen; A Kharazmi; F Espersen; N Høiby
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  A novel model of chronic wounds: importance of redox imbalance and biofilm-forming bacteria for establishment of chronicity.

Authors:  Sandeep Dhall; Danh Do; Monika Garcia; Dayanjan Shanaka Wijesinghe; Angela Brandon; Jane Kim; Antonio Sanchez; Julia Lyubovitsky; Sean Gallagher; Eugene A Nothnagel; Charles E Chalfant; Rakesh P Patel; Neal Schiller; Manuela Martins-Green
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.